Nuvectis Pharma
NVCT
NVCT
11 hedge funds and large institutions have $7.38M invested in Nuvectis Pharma in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.47M |
| 2 |
VF
Virtu Financial
New York
|
$93K |
| 3 |
BWP
Baldwin Wealth Partners
Marion,
Massachusetts
|
$1,000K |
| 4 |
Morgan Stanley
New York
|
$2.26K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$90 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $4.41M | -$341K | -45,527 | -7% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $1.47M | +$1.27M | +168,768 | +624% |
|
|
BWP
3
Baldwin Wealth Partners
Marion,
Massachusetts
| $1,000K | +$2.25K | +300 | +0.2% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $235K | -$547 | -73 | -0.2% |
|
|
VF
5
Virtu Financial
New York
| $93K | +$93K | +12,418 | New |
|
6
State Street
Boston,
Massachusetts
| $87.9K | – | – | – |
|
7
BlackRock
New York
| $76.2K | -$28.8K | -3,842 | -27% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $10K | -$19.8K | -2,693 | -66% |
|
|
9
Morgan Stanley
New York
| $2.26K | +$750 | +100 | +50% |
|
10
Wells Fargo
San Francisco,
California
| $188 | +$8 | +1 | +4% |
|
|
11
Bank of America
Charlotte,
North Carolina
| $90 | +$90 | +12 | New |
|
12
UBS Group
Zurich,
Switzerland
| – | -$2K | -220 | Closed |
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -76 | Closed |
|